VACCINE APPROVED IN U. K. — A VERY PROFITABLE SHORT TERM TRADE ON THE VACCINE STOCK MODERNA

Twitter
LinkedIn
Facebook

The big news is that the vaccine from Pfizer (PFE) and BioNTech (BNTX) has been approved in the U. K.

The vaccine is providing many long term investment opportunities and many short term trading opportunities.

The Chart

Please click here for a chart of vaccine maker Moderna (MRNA).

Note the following:

  • As the chart shows, in the morning Moderna stock was running up like crazy.  The talking was that the stock was going over $200.
  • In the middle of that bullishness, The Arora Report gave a signal not only to sell the long position but to short sell Moderna stock.
  • The chart shows that the Arora sell signal was right at the top.
  • The chart shows that the stock quickly fell over $44 from the time the Arora sell signal was given.
  • The Arora Report gives target zones and stop zones in advance at the same time when a signal is given to initiate a position.
  • Arora target zone hit generating a nice profit.

The Signal

For your convenience, the following post is being reproduced here from ZYX Short Sell Change Alert.

SIGNAL LIMITED: A NEW IDEA ON MRNA

This is suitable only for super aggressive investors.  The short zone for  is $174 to $181.88.   is trading at $174.70 as of this writing.   The stop zone is $183 to $187. The maximum recommended quantity is 10% of full core position size.  Those desiring higher quantity may consider Trade Around positions with closer stops and closer targets.  The first target zone is $143 to $155.

Trades posted on The Arora Report Market Blog have produced unrivalled performance since 2007. These trades have been scrutinized in real-time by thousands of investors across the globe.  This provides easy verification of performance for newcomers to this site.  Only those trades are included in the performance where the entry post was made available to subscribers to The Arora Report Market Blog.  When the entry post is made available only to the paying subscribers and not posted in real-time on The Arora Report Market Blog, the resulting performance of the trade is not credited in the performance table.  There are very nice gains on this trade but since the entry trade was not posted here for the free subscribers in real-time but only made available to the paying subscribers, handsome profits on this trade will not be added to the performance of The Arora Report Market Blog shown on the table.

This post was previously published  on ZYX Short Sell Change Alert.

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Subscribe to 'Generate Wealth'

Free Forever

More To Explore

30 Day Free Trial

Cancel within 30 days and you owe nothing

When you take a FREE 30 day trial, you get access to powerful techniques used by billionaires and hedge funds to grow richer. You can continue to use these powerful techniques to grow richer even if you cancel your subscription. You come out ahead by subscribing no matter how you look at it.

Do you want to gain an edge in the markets? Join thousands of your fellow investors and money managers to subscribe to Generate Wealth newsletter.

 

FREE FOREVER

Follow The Most Accurate Stock Market Analysis

Unrivaled Insights
In Bull and Bear Markets

Generate Wealth Newsletter
Free Forever

Generate Wealth Newsletter
Free Forever